StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26+0.00 (0.00%)

Close on Nov 19, 2026Market cap $248.90MP/E –Yield –

Amarin shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Amarin's shares outstanding was 428M at Sep 30, 2026. For fiscal 2025 it was 415M, up 1.0% from the year before. Over ten years it grew 8.7% a year on average. The highest annual figure on record is 415M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025415M+1.0%
FY2024Dec 31, 2024411M+0.8%
FY2023Dec 31, 2023408M+1.6%
FY2022Dec 31, 2022401M-0.3%
FY2021Dec 31, 2021402M+5.4%
FY2020Dec 31, 2020382M+11.5%
FY2019Dec 31, 2019343M+15.2%
FY2018Dec 31, 2018297M+9.8%
FY2017Dec 31, 2017271M+27.7%
FY2016Dec 31, 2016212M+17.3%
FY2015Dec 31, 2015181M+3.9%
FY2014Dec 31, 2014174M+4.0%
FY2013Dec 31, 2013167M+16.0%
FY2012Dec 31, 2012144M+110472.2%
FY2011Dec 31, 20110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026428M+3.0%
Q2 FY2026Jun 30, 2026416M+0.5%
Q1 FY2026Mar 31, 2026419M+1.4%
Q4 FY2025Dec 31, 2025416M+1.1%
Q3 FY2025Sep 30, 2025416M+1.1%
Q2 FY2025Jun 30, 2025414M+0.7%
Q1 FY2025Mar 31, 2025413M+0.8%
Q4 FY2024Dec 31, 2024411M+0.8%
Q3 FY2024Sep 30, 2024411M+0.7%
Q2 FY2024Jun 30, 2024411M+0.9%
Q1 FY2024Mar 31, 2024410M+1.0%
Q4 FY2023Dec 31, 2023408M+0.8%
Q3 FY2023Sep 30, 2023408M+0.9%
Q2 FY2023Jun 30, 2023408M+2.4%
Q1 FY2023Mar 31, 2023406M+2.1%
Q4 FY2022Dec 31, 2022405M-4.3%
Q3 FY2022Sep 30, 2022405M+2.0%
Q2 FY2022Jun 30, 2022398M-0.9%
Q1 FY2022Mar 31, 2022398M+0.8%
Q4 FY2021Dec 31, 2021423M+8.2%
Q3 FY2021Sep 30, 2021397M+1.8%
Q2 FY2021Jun 30, 2021402M+0.5%
Q1 FY2021Mar 31, 2021395M+9.3%
Q4 FY2020Dec 31, 2020391M+8.7%
Q3 FY2020Sep 30, 2020390M+11.0%
Q2 FY2020Jun 30, 2020400M+20.8%
Q1 FY2020Mar 31, 2020361M+9.9%
Q4 FY2019Dec 31, 2019359M+14.3%
Q3 FY2019Sep 30, 2019351M+18.7%
Q2 FY2019Jun 30, 2019331M+12.7%
Q1 FY2019Mar 31, 2019329M+15.3%
Q4 FY2018Dec 31, 2018314M+16.0%
Q3 FY2018Sep 30, 2018296M+9.2%
Q2 FY2018Jun 30, 2018294M+8.5%
Q1 FY2018Mar 31, 2018285M+5.6%
Q4 FY2017Dec 31, 2017271M+0.5%
Q3 FY2017Sep 30, 2017271M–
Q2 FY2017Jun 30, 2017271M–
Q1 FY2017Mar 31, 2017270M–
Q4 FY2016Dec 31, 2016270M–

More Amarin figures

See a number that looks wrong?